|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2011-5-31
|
|
pubmed:abstractText |
The novel ability to epigenetically reprogram somatic cells into induced pluripotent stem cells (iPSCs) through the exogenous expression of transcription promises to revolutionize the study of human diseases.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1097-6825
|
|
pubmed:author |
pubmed-author:AgarwalSuneetS,
pubmed-author:Al-HerzWaleedW,
pubmed-author:CasanovaJean-LaurentJL,
pubmed-author:DaleyGeorge QGQ,
pubmed-author:GenneryAndrew RAR,
pubmed-author:GilianiSilviaS,
pubmed-author:ManosPhilip DPD,
pubmed-author:MostoslavskyGustavoG,
pubmed-author:NotarangeloLuigi DLD,
pubmed-author:Ordovas-MontanesJoseJ,
pubmed-author:ParkIn-HyunIH,
pubmed-author:PessachItai MIM,
pubmed-author:RucciFrancescaF,
pubmed-author:SchlaegerThorsten MTM,
pubmed-author:ZhangShen-YingSY
|
|
pubmed:copyrightInfo |
Copyright © 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
127
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1400-7.e4
|
|
pubmed:meshHeading |
pubmed-meshheading:21185069-Adaptive Immunity,
pubmed-meshheading:21185069-Cell Dedifferentiation,
pubmed-meshheading:21185069-Cell Differentiation,
pubmed-meshheading:21185069-Cell Line,
pubmed-meshheading:21185069-Cell Transdifferentiation,
pubmed-meshheading:21185069-DNA,
pubmed-meshheading:21185069-Gene Expression,
pubmed-meshheading:21185069-Genes, myc,
pubmed-meshheading:21185069-Humans,
pubmed-meshheading:21185069-Immunity, Innate,
pubmed-meshheading:21185069-Immunologic Deficiency Syndromes,
pubmed-meshheading:21185069-Induced Pluripotent Stem Cells,
pubmed-meshheading:21185069-Karyotyping,
pubmed-meshheading:21185069-Kruppel-Like Transcription Factors,
pubmed-meshheading:21185069-Octamer Transcription Factor-3,
pubmed-meshheading:21185069-SOXB1 Transcription Factors
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies.
|
|
pubmed:affiliation |
Division of Immunology, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
